| Entry |
|
| Name |
Interferon beta (JAN); Feron (TN) |
| Class |
Immunological agent
DG01752 Interferone
|
| Remark |
| Product (DG01751): | D00746<JP/US> D04554<JP/US> |
|
| Efficacy |
Antineoplastic, Antiviral, Biological response modifier |
| Target |
|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
| hsa04620 | Toll-like receptor signaling pathway |
| hsa04650 | Natural killer cell mediated cytotoxicity |
|
| Interaction |
|
| Structure map |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 IMMUNOSTIMULANTS
L03A IMMUNOSTIMULANTS
L03AB Interferons
L03AB02 Interferon beta natural
D03304 Interferon beta (JAN)
Drug groups [BR:br08330]
Immunological agent
DG01752 Interferone
DG01751 Interferon beta
D03304 Interferon beta
Drug classes [BR:br08332]
Immunological agent
DG01752 Interferone
D03304 Interferon beta
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Interferon receptors
IFNAR1
D03304 Interferon beta (JAN)
IFNAR2
D03304 Interferon beta (JAN)
Antimicrobials [BR:br08307]
Antivirals
Entry, fusion or uncoating inhibitor
Interferon
D03304 Interferon beta (JAN)
Drug groups [BR:br08330]
Immunological agent
DG01752 Interferone
DG01751 Interferon beta
|
| Other DBs |
|
| LinkDB |
|